{"id":"gliolan","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Photosensitivity"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL1200582","moleculeType":"Small molecule","molecularWeight":"167.59"},"aliases":["ALA","5-Aminolevulinic Acid Hydrochloride (5-ALA)","5-Aminolevulinic acid","5-ALA"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T02:38:31.821Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Actinic keratosis","diseaseId":"actinic-keratosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Fluorescent stain","diseaseId":"fluorescent-stain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-Hyperkeratotic Actinic Keratoses","diseaseId":"non-hyperkeratotic-actinic-keratoses","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06665724","phase":"PHASE1","title":"Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2025-01-27","conditions":"Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)","enrollment":16},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT03048240","phase":"NA","title":"INtraoperative photoDYnamic Therapy of GliOblastoma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2017-05-05","conditions":"Glioblastoma","enrollment":10},{"nctId":"NCT02473380","phase":"PHASE1","title":"Fluorescence Spectroscopy Guided Surgery","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-08","conditions":"Low Grade Glioma (LGG), High Grade Glioma (HGG)","enrollment":11},{"nctId":"NCT04738162","phase":"PHASE2","title":"Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2020-09-25","conditions":"Brain Tumor, Pediatric","enrollment":78},{"nctId":"NCT04391062","phase":"PHASE2","title":"Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2021-09-28","conditions":"Glioblastoma","enrollment":14},{"nctId":"NCT04400539","phase":"PHASE2","title":"The IMmunotherapy Pleural 5-ALA PDT","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2022-05-09","conditions":"Mesotheliomas Pleural, Malignant Pleural Mesothelioma","enrollment":20},{"nctId":"NCT06948552","phase":"PHASE2","title":"Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA","status":"NOT_YET_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2025-05","conditions":"Upper Tract Urothelial Carcinoma","enrollment":10},{"nctId":"NCT06678867","phase":"PHASE2","title":"The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours","status":"NOT_YET_RECRUITING","sponsor":"University College, London","startDate":"2025-03-25","conditions":"Brain Tumor","enrollment":80},{"nctId":"NCT04469699","phase":"PHASE2","title":"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","status":"TERMINATED","sponsor":"University Hospital Muenster","startDate":"2021-04-12","conditions":"Glioblastoma Multiforme, Adult","enrollment":30},{"nctId":"NCT05590689","phase":"PHASE1, PHASE2","title":"Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor","status":"RECRUITING","sponsor":"Universität Münster","startDate":"2022-11-09","conditions":"Glioblastoma","enrollment":34},{"nctId":"NCT04164849","phase":"PHASE1, PHASE2","title":"Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2019-11-22","conditions":"Crohn Disease","enrollment":7},{"nctId":"NCT01502280","phase":"PHASE3","title":"Fluorescence-guided Surgery for Low- and High-grade Gliomas","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2010-11","conditions":"Glioma","enrollment":127},{"nctId":"NCT05850377","phase":"","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Sociedad de Lucha Contra el Cáncer del Ecuador","startDate":"2023-06-01","conditions":"High Grade Glioma, Glioma, Glioma, Malignant","enrollment":90},{"nctId":"NCT02698293","phase":"PHASE1","title":"PDT Plus Vitamin D3 for Anal Dysplasia","status":"WITHDRAWN","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2019-12-01","conditions":"Anal Dysplasia, Carcinoma in Situ","enrollment":""},{"nctId":"NCT02632370","phase":"","title":"5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor","status":"COMPLETED","sponsor":"Constantinos Hadjipanayis","startDate":"2016-05","conditions":"Malignant Gliomas","enrollment":69},{"nctId":"NCT01310868","phase":"PHASE2","title":"Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma","status":"COMPLETED","sponsor":"University College, London","startDate":"2011-05","conditions":"Glioblastoma","enrollment":59},{"nctId":"NCT02755142","phase":"PHASE1, PHASE2","title":"Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas","status":"COMPLETED","sponsor":"medac GmbH","startDate":"2000-02","conditions":"Brain Neoplasm","enrollment":21},{"nctId":"NCT01445691","phase":"PHASE2","title":"More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery","status":"WITHDRAWN","sponsor":"Constantinos Hadjipanayis","startDate":"2015-11","conditions":"Benign Neoplasms, Brain, Brain Cancer, Brain Neoplasms, Benign","enrollment":""},{"nctId":"NCT02101931","phase":"PHASE3","title":"A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine","status":"COMPLETED","sponsor":"Princess Al-Johara Al-Ibrahim Cancer Research Center","startDate":"2014-03","conditions":"Transitional Cell Carcinoma of the Bladder","enrollment":100},{"nctId":"NCT02240758","phase":"PHASE1","title":"Confocal Laser Endomicroscopy for Brain Tumors","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2014-09","conditions":"Low Grade Glioma (LGG), High Grade Glioma (HGG)","enrollment":10},{"nctId":"NCT01697670","phase":"PHASE1","title":"Photodynamic Therapy for Ulcerative Colitis","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2012-09","conditions":"Ulcerative Colitis","enrollment":7}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"Gliolan","genericName":"Gliolan","companyName":"Abramson Cancer Center at Penn Medicine","companyId":"abramson-cancer-center-at-penn-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":5,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}